It’s good to see oncology recognize that olanzapine can induce akathisia in up to 16% of reported cases. As a result of akathisia, cancer patients “may experience significant distress.” Further, clinicians can easily miss or misdiagnose akathisia symptoms, leading to worse outcomes.

Read more at https://ascopubs.org/doi/full/10.1200/JCO.23.00853.